Heritage Investors Management Corp lessened its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 106,771 shares of the pharmacy operator’s stock after selling 7,075 shares during the period. Heritage Investors Management Corp’s holdings in Walgreens Boots Alliance were worth $7,296,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Northside Capital Management LLC boosted its position in shares of Walgreens Boots Alliance by 2.3% in the 4th quarter. Northside Capital Management LLC now owns 8,335 shares of the pharmacy operator’s stock worth $570,000 after purchasing an additional 184 shares in the last quarter. First Bank & Trust lifted its position in Walgreens Boots Alliance by 5.9% in the 4th quarter. First Bank & Trust now owns 3,410 shares of the pharmacy operator’s stock valued at $233,000 after acquiring an additional 189 shares in the last quarter. Brand Asset Management Group Inc. lifted its position in Walgreens Boots Alliance by 40.7% in the 4th quarter. Brand Asset Management Group Inc. now owns 692 shares of the pharmacy operator’s stock valued at $47,000 after acquiring an additional 200 shares in the last quarter. Cornerstone Advisors Inc. lifted its position in Walgreens Boots Alliance by 102.4% in the 3rd quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 214 shares in the last quarter. Finally, Andesa Financial Management Inc. lifted its position in Walgreens Boots Alliance by 5.8% in the 4th quarter. Andesa Financial Management Inc. now owns 4,253 shares of the pharmacy operator’s stock valued at $291,000 after acquiring an additional 232 shares in the last quarter. Institutional investors own 66.57% of the company’s stock.
In related news, Director Nancy M. Schlichting sold 7,050 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total transaction of $555,610.50. Following the transaction, the director now directly owns 5,709 shares of the company’s stock, valued at $449,926.29. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 EPS for the quarter, topping the Zacks’ consensus estimate of $1.43 by $0.03. The business had revenue of $33.79 billion for the quarter, compared to analyst estimates of $33.90 billion. Walgreens Boots Alliance had a net margin of 3.96% and a return on equity of 22.17%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same period last year, the company posted $1.28 earnings per share. Sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 6.52 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Friday, February 15th will be issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 2.43%. The ex-dividend date of this dividend is Thursday, February 14th. Walgreens Boots Alliance’s payout ratio is 29.24%.
Several equities analysts recently issued reports on the company. Loop Capital set a $82.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 23rd. UBS Group assumed coverage on shares of Walgreens Boots Alliance in a research note on Thursday, January 17th. They set a “sell” rating and a $70.00 target price for the company. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, January 2nd. Needham & Company LLC upgraded shares of Walgreens Boots Alliance to a “buy” rating and set a $94.00 target price for the company in a research note on Thursday, December 20th. Finally, Robert W. Baird reduced their price objective on Walgreens Boots Alliance from $71.00 to $70.00 and set a “neutral” rating for the company in a research note on Friday, December 21st. Four analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company’s stock. Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $78.83.
WARNING: This story was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/02/14/heritage-investors-management-corp-has-7-30-million-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: What is an SEC Filing?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.